Showing 51–75 of 136 · North America
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Listed (HOLX); FY2025 full-year figures not yet captured, so not assessed.
Agreed in Oct 2025 to be acquired by Blackstone and TPG funds (up to $79 a share).
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $67.53bn (+7.6%); pre-tax margin 15.3%; net income $10.59bn.
Cash $14.50bn; debt $61.30bn.
Part of RadNet (RDNT).
Latest full-year results not yet captured by HSH.
FY2025 revenue $2.23bn (-6.3%); operating margin 1.9%; net income $0.7m.
Cash $308.0m; debt $1.28bn.
FY2025 revenue $4.34bn (-0.7%); operating margin 18.6%; net income $850.0m.
Cash $1.63bn; debt $1.99bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $2.71bn (+30.7%); operating margin 17.5%; net income $247.1m.
Cash $716.1m; debt $949.2m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $10.06bn (+20.5%); operating margin 29.3%; net income $2.86bn.
No debt; $9.03bn cash and investments.
FY2025 revenue $16.31bn (+5.9%); operating margin 13.4%; net income $1.36bn.
Cash $1.98bn; debt $15.72bn.
Parent Johnson & Johnson (JNJ) group FY2025 revenue $94.19bn (+6.0%); pre-tax margin 34.6%; net income $26.80bn.
MedTech segment sales $33.79bn (+6.1%).
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue $1.53bn (+9.4%).
Preliminary revenue only; full GAAP results not yet captured.
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
Part of Dassault Systèmes (DSY.PA).
Latest full-year results not yet captured by HSH.